Article | Open

Silver-nanoparticles-modified biomaterial surface resistant to staphylococcus: new insight into the antimicrobial action of silver

  • Scientific Reports 6, Article number: 32699 (2016)
  • doi:10.1038/srep32699
  • Download Citation
Published online:


Titanium implants are widely used clinically, but postoperative implant infection remains a potential severe complication. The purpose of this study was to investigate the antibacterial activity of nano-silver(Ag)-functionalized Ti surfaces against epidemic Staphylococcus from the perspective of the regulation of biofilm-related genes and based on a bacteria-cell co-culture study. To achieve this goal, two representative epidemic Staphylococcus strains, Staphylococcus epidermidis (S. epidermidis, RP62A) and Staphylococcus aureus (S. aureus, USA 300), were used, and it was found that an Ag-nanoparticle-modified Ti surface could regulate the expression levels of biofilm-related genes (icaA and icaR for S. epidermidis; fnbA and fnbB for S. aureus) to inhibit bacterial adhesion and biofilm formation. Moreover, a novel bacteria-fibroblast co-culture study revealed that the incorporation of Ag nanoparticles on such a surface can help mammalian cells to survive, adhere and spread more successfully than Staphylococcus. Therefore, the modified surface was demonstrated to possess a good anti-infective capability against both sessile bacteria and planktonic bacteria through synergy between the effects of Ag nanoparticles and ion release. This work provides new insight into the antimicrobial action and mechanism of Ag-nanoparticle-functionalized Ti surfaces with bacteria-killing and cell-assisting capabilities and paves the way towards better satisfying the clinical needs.


Commercial titanium (Ti) and titanium alloys have been utilized as biomedical implants for many years, on account of their intrinsic biocompatibility, prominent mechanical properties and good anti-corrosive quality1. However, Ti-based implants exhibit poor biological activity, resulting in insufficient osseointegration1; moreover, they are subject to problems of bacterial adhesion and subsequent biofilm formation, also known as implant-related infection, which leads to implant failure2,3,4. The incidence of biomaterial-associated infection (BAI) in orthopaedics has been reported to be between 2% and 5% in recent years5. Accordingly, there is an urgent need to improve the surface performance of Ti-based implants to hinder the formation of pathogen biofilms and promote tissue bio-integration with tissue6,7.

In order to improve the antimicrobial and anti-biofilm properties of implants, numerous processing methods have been developed for the surface modification of Ti-based implants8,9,10,11,12. One of the most common treatments is to coat the surface with antibiotics, but this approach may cause the drug-resistance and the emergence of deadly superbugs, such as methicillin-resistant Staphylococcus aureus (MRSA)13,14,15. As an alternative, inorganic antibacterial elements, such as silver (Ag) and copper (Cu), have also been used to offset the above concerns, especially Ag, which is widely known to exhibit broad-spectrum bactericidal or bacteriostatic activity at low concentrations without producing resistant bacteria16,17,18,19. In our previous work, silver nanoparticles (Ag NPs) fixed on Ti-based biomaterials through plasma immersion ion implantation (PIII) showed excellent anti-biofilm activity against adhesive bacteria, but this contact-killing surface could not exert an antiseptic effect on planktonic bacteria due to a lack of silver ion release8. However, if a slow and persistent release of silver ions (Ag+) could be achieved through careful design of the Ag NPs based on existing methods, then we hypothesize that the resultant modified coating would provide long-term antibacterial efficacy, effectively killing planktonic bacteria and preventing the surface adhesion of pathogens simultaneously. At the same time, it must be considered that excessive levels of Ag+ have the potential to demonstrate cytotoxicity20,21,22; thus, the concentration of the released Ag+ should strike a balance between tissue biocompatibility and pathogen-killing efficacy23. At present, numerous methods are available for loading implant surfaces with Ag, such as physical vapor deposition (PVD), PIII, plasma electrolytic oxidation (PEO), and chemical reduction, etc. However, it may be not easy to control Ag loading capacity using PVD, and it is difficult to release Ag+ from Ag NPs deposited by PIII because they typically become embedded in the Ti surface. Compared with these physically processing methods, hydrothermal chemistry method (HCM) offers certain advantages, such as controllable loading capacity, adjustable surface morphology, etc.24,25,26. This inspired us to investigate the HCM as a promising strategy for loading Ag onto Ti surface. In addition, a PEO-fabricated titania (TiO2) coating was selected for the pre-modifying layer on the Ti surface because PEO can produce porous, homogeneous and firmly adherent titania layers with favorable biocompatibility and bioactivity27,28,29,30. Moreover, previous literatures have manifested that inorganic ions deposited on the porous titania coating could present a pattern of sustained release instead of explosive release31,32.

Previous studies of the anti-biofilm properties of modified biomaterials have concentrated on the ica-dependent biofilm mechanism which plays an undeniably important role in staphylococcal biofilm development8,33; however, increasing evidences begin to emphasize the existence of an ica-independent biofilm mechanism, which is also involved in the pathogenesis of biomaterial-related infections, in both S. aureus and S. epidermidis34,35. This novel biofilm phenotype, as recently identified in a research on MRSA strains, is facilitated by the fibronectin (Fn)-binding proteins (FnBPs), i.e., FnBPA and FnBPB36. Hence, we sought to investigate whether a well-decorated Ti surface could exert their resistant effects against both the ica-dependent and FnBP-promoted biofilm mechanisms.

A surgical procedure offers an opportunity for contaminating bacteria to enter the acute wound, and any inserted surgical devices are also subject to consequent bacterial colonization. Thus, the fate of an implant surface may be pictured as a race between peri-implant tissue cells and invading bacteria37. If the bacteria win, the implant will be occupied by a biofilm and have to be replaced, and host tissues around the implant will also be destroyed by virulent pathogens38,39. However, if host tissue cells can availably cover the surface before their opponents, this will make the implant less vulnerable to bacteria and serve as the effective safeguard against implant infection39,40. Considering the bacterially contaminated perioperative period41, we intended to discover whether our proposed modified coating could help mammalian cells to win the race for occupying the implant surface; and if so, the prophylaxis for BAI could be perfectly implemented.

To this end, we first prepared porous titania coatings on Ti surfaces, followed by hydrothermal treatment to refine titania grains and deposit Ag nanoparticles, with the intent of compensating for the potential cytotoxicity of Ag+ by means of a synergistic effect between the hierarchical topography and chemical composition of the surface. On this basis, we then investigated the prepared surfaces to systematically evaluate the antimicrobial activity, biofilm resistance, and related genes expression for two types of biofilms. Moreover, we determined whether the fibroblast cells were favoured with respect to occupation of the modified surfaces through an in vitro bacteria-cell co-culture experiment.


Sample characterization

The entire process of fabricating specimens is illustrated in Fig. 1; this process consisted of a two-step strategy of plasma electrolytic oxidation for the formation of TiO2 coatings and hydrothermal chemical treatment for the loading of Ag nanoparticles. As shown in Fig. 2a, for the TiO2 samples, a relatively smooth topography was observed on the Ti surface at high magnification after the PEO treatment. At low magnification (inset), the Ti surface exhibited a porous morphology, a typical characteristic of this surface modification method. By contrast, for the Ag-0 samples, a unique nanoawl structure, nearly perpendicular to Ti surface, was produced by the hydrothermal treatment in ultrapure water (Fig. 2b), although the porous topography was not obviously altered. It is inferred that the nanoawls originated from the refinement of the grains during the hydrothermal treatment. Furthermore, the grain size increased with the addition of silver acetate, as shown in Fig. 2c (Ag-0.01 sample). It can also be seen that tiny nanoparticles were deposited on the nanoawls. This could be observed more clearly for the Ag-0.1 samples (Fig. 2d). However, their low-magnification porous morphology was not significantly changed. According to the energy disperse spectroscopy (EDS) analysis results presented in Table 1, the Ag loading amounts for the Ag-0.01 and Ag-0.1 samples were 0.24 wt% and 2.29 wt%, respectively. As seen from the X-ray diffractometer (XRD) patterns in Fig. 2e, for all samples, the surface coatings predominantly consisted of anatase-phase titania and rutile-phase titania. Interestingly, according to the Raman spectra in Fig. 2f, the outermost surface layers of these samples contained only the anatase phase, particularly in the case of the hydrothermally treated samples, as the peaks at 145 cm−1, 197 cm−1, 399 cm−1, 518 cm−1 and 638 cm−1 are all associated with vibrations in anatase titania crystal42.

Figure 1: Schematic illustration of the fabrication process for the samples, including plasma electrolytic oxidation and hydrothermal chemical treatment.
Figure 1
Figure 2
Figure 2

Surface morphologies of the TiO2 (a), Ag-0 (b), Ag-0.01 (c) and Ag-0.1 (d) samples and the corresponding XRD patterns (e) and Raman spectra (f) acquired from the surfaces of the various samples. The red arrows in (c) and (d) indicate Ag NPs.

Table 1: Elemental composition of various samples analyzed by EDS technique.

To investigate the form in which the silver component was present on the surface, the transmission electron microscope (TEM) analysis was performed on the Ag-0 and Ag-0.1 samples. Figure 3a,b shows typical bright-field TEM images of the titania nanoawls scratched off from the surfaces of Ag-0 samples. The corresponding high-resolution image in Fig. 3c clearly reveals a set of fringes, indicating the anatase single-crystalline nature of the titania nanoawls, which is consistent with the selected area electron diffraction (SAED) pattern shown in the inset. With regard to the Ag-0.1 samples, as shown in Fig. 3d, bright-field imaging revealed the presence of tiny nanoparticles. Combined with the in situ EDS analysis results, the findings confirmed these tiny nanoparticles to be silver nanoparticles. Figure 3e provides a more detailed depiction of the bright-field features of the tiny nanoparticles. Upon in situ EDS analysis, the tiny nanoparticles in Fig. 3f were verified to be silver nanoparticles. The high- resolution fringes and the corresponding SAED pattern further indicated the successful deposition of metallic silver nanoparticles on the titania nanoawls.

Figure 3
Figure 3

TEM analysis results for TiO2 (a–c) and Ag-0.1 (d–f) samples, including morphologies, HRTEM results, SAED results and the results of EDS elemental analysis.

Taking the Ag-0.1 samples as an example, the X-ray photoelectron spectroscopy (XPS) analysis was also conducted to further investigate the surface chemical composition and valence state. As shown in Fig. 4a, elements of Ti, oxygen (O), calcium (Ca) and phosphorus (P) were detected in the TiO2 coating, and after silver deposition via the hydrothermal method, the presence of silver could be clearly observed from the full XPS spectrum. Figure 4b shows the high-resolution Ag 3d XPS spectrum. The Ag 3d doublets centred at 368.2 eV for Ag 3d5/2 and 374.2 eV for Ag 3d3/2, with a spin energy separation of 6.0 eV, were assigned to metallic silver43,44, consistent with the TEM analysis (Fig. 3f). The high-resolution Ti 2p XPS spectrum, as shown in Fig. 4c, also contained two peaks, at 464.5 eV for Ti 2p1/2 and 458.8 eV for Ti 2p3/2 in the titania45. Similarly, the O 1s XPS spectrum (Fig. 4d) could be divided into two peaks at 529.3 eV for Ti-O-Ti and 531.2 eV for Ti-OH46.

Figure 4
Figure 4

Full XPS spectra (a) acquired from the surfaces of TiO2 and Ag-0.1 samples, accompanied by the corresponding high-resolution Ag 3d (b), Ti 2p (c) and O 1s (d) XPS spectra. Release profiles of free silver matter in TSB (e) and ultrapure water (f) and the concomitant release of calcium ions (g) and phosphorus ions (h) in ultrapure water over 14 days.

In addition, the ion release profiles for various elements, including silver, calcium, phosphorus and titanium were detected via inductively coupled plasma optical emission spectrometry (ICP-OES). As shown in Fig. 4e, both Ag-0.01 and Ag-0.1 samples were found to exhibit sustained release of free silver ions in agar-free trypticase soy broth (TSB) medium over the 14 d of immersion. An obvious gap between the Ag-0.01 and Ag-0.1 samples can also be seen in this figure, which was due to their different levels of loading with free silver matter. This was also true when ultrapure water was used as the incubation medium (Fig. 4f). In addition, as seen from Fig. 4g,h, both calcium and phosphorus ions were released from all sample surfaces during the investigated period; however, no titanium species were detected.

In vitro bioactivity

The apatite-forming ability of an implant in a physiological environment plays an important role in cell response and osseointegration. An in vitro immersion test in simulated body fluid (SBF) is typically conducted to estimate the surface bioactivity of a biomaterial. As shown in Fig. 5a, after 7 d of immersion in SBF, the TiO2 samples retained a bare surface morphology because of the bioinertia of the coating1. By contrast, spherical clusters appeared on the surfaces of the Ag-0 samples, consisting of subtle wormlike structures at high magnification (inset). As shown in Fig. 5b, characteristic diffraction peaks of crystalline apatite were clearly detected at 2θ = 26° and 32° in the XRD pattern, indicating that these sphere-like particles were assemblies of tiny apatite crystals. As for the Ag-0.01 samples, the surfaces were also partially covered with a discontinuous layer of spherical apatite clusters. However, the surface bioactivity of the Ag-0.1 samples was decreased compared with the Ag-0.01 samples. This was further confirmed by the relative changes in the intensities of the peaks corresponding to apatite (at 2θ = 32°) and anatase (at 2θ = 25.2°) in Fig. 5b. With the prolongation of the immersion time to 14 d, the TiO2 samples still remained bare, without any apatite clusters on their surface. On the contrary, the surfaces of both the Ag-0 and Ag-0.01 samples were completely covered with a newly formed layer of spherical apatite clusters exhibiting subtle a wormlike texture at high magnification, demonstrating their good bioactivity. In comparison, the surfaces of the Ag-0.1 samples were only partially covered with a discontinuous apatite layer. As expected, these observations were consistent with the results for 7 d of immersion, as further supported by the changes in the relative intensities of the anatase peak at 2θ = 25.2° and the apatite peak at 2θ = 32° in Fig. 5c.

Figure 5
Figure 5

(a) Evolution of the surface morphologies of TiO2, Ag-0, Ag-0.01 and Ag-0.1 samples after immersion in SBF for 7 days and 14 days. (b–c) Surface XRD patterns of TiO2, Ag-0, Ag-0.01 and Ag-0.1 samples after immersion in SBF for 7 days and 14 days.

Antimicrobial and anti-biofilm properties

In this test, S. epidermidis and S. aureus, which are the most common microorganisms involved in orthopaedic implant infection and biofilm formation, were utilized to investigate the antimicrobial and anti-biofilm properties of our samples35,47. S. epidermidis (RP62A) and S. aureus (USA300) were selected as representatives of the two types of biofilm formation mechanisms, i.e., ica-dependent and ica-independent mechanisms, respectively8,48.

Biocidal performance against planktonic bacteria

As shown in Fig. 6a,b, after 18 h of exposure, the amounts of the planktonic bacteria S.epidermidis (RP62A, CFU/ml) decreased from 8.1 in the TiO2 control and 8.0 in the Ag-0 group to 5.7 in the Ag-0.01 group (P < 0.01) and 4.6 in isolates exposed to Ag-0.1 (P < 0.001). Moreover, the amounts of S.aureus (USA300, CFU/ml) decreased from 8.3 in the control and 8.2 in the Ag-0 specimens to 5.8 and 4.6 in the silver-exposed isolates (Ag-0.01, P < 0.01, and Ag-0.1, P < 0.001, respectively). These results indicate that TiO2-Ag (Ag-0.01 and Ag-0.1) samples exert damaging effects on the planktonic bacteria. Moreover, compared with the Ag-0.01 group, the Ag-0.1 group appeared to present slightly stronger antibacterial activity, although there was no statistically significant difference between them. The antibacterial efficiency against swimming bacteria was also qualitatively evaluated based on the representative spread plate method (SPM) pictures. As shown in Fig. 6c, the numbers of live bacteria in the TiO2 and Ag-0 groups were far greater than those in the TiO2-Ag groups, and the trend is consistent with the above quantitative results described above.

Figure 6: Antibacterial properties against planktonic bacteria in vitro at the end of the experiment.
Figure 6

Subfigures (a) and (b) present the quantitative antibacterial effects on the CFU values in the media for RP62A and USA300, respectively. Significantly decreased CFU/ml counts of floating bacteria were observed. **P < 0.01, ***P < 0.001. Subfigure (c) shows typical photographs of two types of re-cultivated planktonic bacteria colonies on SBA plates.

Antimicrobial activity against sessile bacteria

As infecting organisms, S. epidermidis and S. aureus are usually either introduced during the insertion of implants or derived from a transient bacteraemia; and they can then adhere to the surface of implants and form a biofilm, namely, an organized bacterial consortium enclosed in a self-produced extracellular matrix35. Hence, the bacterial biofilm plays a very crucial role in the pathogenesis of implant-related infection. In our experiment, as shown in Fig. 7a,b, we found that after culturing overnight, the amounts of S.epidermidis (RP62A, CFU/ml) decreased from 7.3 in both the TiO2 control and Ag-0 groups to 4.7 in the Ag-0.01 samples (P < 0.01) and 2.7 in the Ag-0.1 samples (P < 0.001). And the amounts of S.aureus (USA300, CFU/ml) decreased from 7.1 in the control group and 7.2 in the Ag-0 group to 4.8 and 2.9 for the silver-containing specimens (Ag-0.01, P < 0.01,and Ag-0.1, P < 0.001, respectively). Compared to the Ag-0.01 samples, the Ag-0.1 samples presented stronger antibacterial activity (P < 0.01). This suggests that TiO2 -Ag samples are effective in preventing bacterial colonization on their surfaces. This trend of inhibiting bacterial adhesion was also verified by scanning electron microscopy (SEM) and confocal laser scanning microscopy (CLSM) observations for both kinds of bacteria. As observed from the SEM profiles, as shown in Fig. 7c, many bacteria adhered to the surfaces of the TiO2 and Ag-0 samples, aggregating into grapelike colonies to develop a biofilm. In contrast, not many bacteria were present on the surfaces of the Ag-0.01 samples, indicating that these specimens could prevent bacteria adherence and biofilm formation. Moreover, almost no bacterial cells could be observed on the Ag-0.1 samples, indicating no biofilm formation. In the CLSM images presented in Fig. 7d, we observed intense green fluorescence but only feeble red fluorescence in the TiO2 and Ag-0 samples, which indicated the presence of a sea of live bacteria attached to the surfaces and distinct biofilm formation, whereas, moderate green fluorescence and slightly more red fluorescence could be observed on the surfaces of the Ag-0.01 specimens, and relatively little green and red fluorescence could be detected on the Ag-0.1 surfaces. These findings implied less bacterial adhesion and a lower level of biofilm development on the Ag-0.01 surfaces and the adhesion of very few bacteria and nearly no biofilm formation on the Ag-0.1 surfaces. These observations were consistent with the results acquired by SEM.

Figure 7: Antibacterial capability against sessile bacteria in vitro at the end of the experiment.
Figure 7

Subfigures (a) and (b) present the quantitative antibacterial effects on the CFU value on the samples for RP62A and USA300, respectively. Significantly decreased CFU/ml counts of adherent bacteria were observed. **P < 0.01, ***P < 0.001. Subfigure (c) shows the SEM morphologies of the two types of biofilms on four specimen surfaces. The inner blue box corresponds to ×10000 magnification. The outer large box corresponds to ×3000 magnification. Subfigure (d) shows projected top views of the two types of biofilms on four sample surfaces obtained via CLSM at ×400 magnification. The scale bar represents 25 μm. The blue arrows indicate red fluorescence in the images.

Analyses of the expression of biofilm-related genes

Quantitative real-time PCR analysis was implemented to investigate whether our specimens could exert an effect on the expression of key genes during biofilm formation. Here, 16s rRNA was used for normalization, and the outcomes were formulated as gene expression levels relative to the TiO2 group. The expression levels of icaA and icaR, which participate in RP62A biofilm formation, are shown in Fig. 8a,b. Compared with those in the TiO2 and Ag-0 groups, the expression level of icaA was dramatically decreased in the Ag-0.01 group (P < 0.05), but the expression of icaR was markedly upregulated in the Ag-0.01 group (P < 0.01). Moreover, regarding USA300 biofilm formation, fnbA and fnbB gene expression analyses indicated that the Ag-0.01 samples could suppress biofilm formation by downregulating the expression of fnbA and fnbB, as shown in Fig. 8c,d. Interestingly, during both types of biofilm formation, the expression levels of all involved genes in the Ag-0.1 group were close to 0, which indicated that the inoculated bacteria were exposed to sufficient silver during the early stage that the growth of the bacteria was inhibited and their RNA could not be harvested at the end of incubation.

Figure 8
Figure 8

Relative levels of icaA (a) and icaR (b) expressed by S. epidermidis and fnbA (c) and fnbB (d) expressed by S. aureus cultured with four different samples. The expression levels of the biofilm genes are normalized with respect to the 16S rRNA gene. *P < 0.05, **P < 0.01.

In vitro cytocompatibility

HT1080 cells were employed to evaluate the cytotoxicity of various specimens by means of the Cell Counting Kit-8 (CCK-8) assay. As shown in Fig. 9a, no statistically significant difference relative to TiO2 (control) was found for the Ag-0 and Ag-0.01 groups at each time point, which indicated that the titania micropore/nanoawl coatings and the subsequently formed Ag-doped(0.01 g/l) titania coating exhibited no obvious cytotoxicity and thus can be considered suitable for the potential applications. However, in the course of the experiment, the Ag-0.1 group exerted an obvious cytotoxic effect on the fibroblast cells, suggesting that excessive Ag content can still induce cytotoxicity; thus the Ag-0.1 specimens were deemed unfit for further study, although the Ag-0.1 specimens displayed the strongest antibacterial and anti-biofilm capability.

Figure 9: Cytotoxicity test and antibacterial assessment in a bacteria-fibroblast co-culture system.
Figure 9

(a) Results of a CCK-8 assay showing the cytocompatibility for HT1080 cells cultured on micro-arc-oxidized TiO2 coatings with and without Ag doping. **P <  0.01 vs the Ag-0.1 group. (b) Schematic illustration of the co-culturing process for the fibroblasts, bacteria and samples. (c) Fluorescent images of fibroblast cells on four different specimens contaminated with PR62A or USA300 after staining with DAPI (blue) and TRITC-phalloidin (red). (d–e) The corresponding surface coverages of the four samples contaminated with RP62A or USA300. ***P < 0.001.

In vitro bacteria-fibroblasts co-culture study

In comparison with previous mono-culture studies using only with either mammalian cells or bacteria, our bacteria-fibroblast co-culture study, as illustrated in Fig. 9b, was better representative of the conditions of the clinical practice. The adhesion and growth of the fibroblasts were analysed based on immunocyto-stained fluorescent images (ISFIs). After 36 h, as shown in Fig. 9c, the TiO2 and Ag-0 surfaces showed no living fibroblast cells. Few cells, with a wizened morphology, were present on the Ag-0.1 surfaces. However, a large number of robust fibroblasts attached to the surfaces of the Ag-0.01 samples. As depicted in Fig. 9d,e, in terms of the surface coverage by the cells, there was no fibroblast surface coverage on the TiO2 or Ag-0 surfaces, demonstrating that the presence of adherent bacteria affected the survival of fibroblast cells. The percentages of surface coverage on the Ag-0.1 samples were only 4.6% and 4.6% for RP62A and USA300, respectively. However, for the RP62A- and USA300- contaminated surfaces, the surface coverage percentages on the Ag-0.01 samples reached 48.5% and 50.6%, respectively.


As shown in Fig. 2, obvious titania nanoawl structures were produced on the surfaces of the coatings by the hydrothermal treatment. Meanwhile, Ti-OH groups were also formed on the surfaces during this process. Both the titania nanoawls and the Ti-OH groups synergistically contributed to the surface bioactivity to induce apatite formation26. During immersion in SBF, Ti-OH interacts with OH in the SBF to produce a negatively charged surface with Ti-O terminal groups (Ti − OH + OH → Ti − O + H2O), which are beneficial for apatite formation49. However, the deposition of silver nanoparticles can induce a positively shift in the surface charge thus degrading the surface bioactivity8, which may account for the decreased surface bioactivity of the Ag-0.1 samples.

When dissolved in bacterial solution, the Ag NPs deposited on the PEO-treated titania coatings could convert into Ag+, which could then kill microorganisms. Although the antibacterial mechanisms of Ag+ are not yet completely understood, it is generally recognized that Ag+ plays a critical role in binding with intracellular biological groups, such as proteins and nucleic acid, interfering with their function and ultimately leading to cell death17,23,50. In our tests of two Gram-positive bacteria, our TiO2-Ag samples demonstrated powerful biocidal activity against both, and with an increasing dose of silver, the antimicrobial efficacy became stronger.

Regarding the prominent anti-biofilm activity of the TiO2-Ag samples, we consider that there are two possible explanations, as follows. On the one hand, the independent effect of Ag NPs combined with their active physicochemical properties result in anti-biofilm activity17. Physical contact between Ag NPs and bacterial cell walls results in the formation of pits and is sufficient to produce a cytotoxic signal and induce cell death51,52. Moreover, direct contact of Ag NPs with bacterial cell membranes can damage the integrity of the membranes, causing the leakage of cellular components53. On the other hand, in addition to the antiseptic effect of the Ag NPs themselves, the Ag+ ions derived from the Ag NPs can attach to the bacterial cell walls and enter into cytoplasm to destroy the intracellular structures as a secondary effect54. Therefore, the investigated TiO2-Ag specimens can provide a systematic anti-biofilm capability for two typical kinds of bacteria. To further explore the specific anti-biofilm mechanisms, it is necessary to investigate the regulation effect of the modified surfaces on the expression levels of biofilm-related genes.

The complex mechanisms that drive the formation of a functional, mature staphylococcal biofilm are still poorly understood35. However, according to in vitro experimental models, it is generally recognized as a four-step process: (1) bacterial adhesion to the implant surface (2) bacterial aggregation into multiple cell layers (3) maturation of the biofilm architecture and (4) separation of cells from the mature biofilm into the floating state to start a new cycle of biofilm formation35,55. And at present, the prevention of biofilm formation can be achieved through two main approaches, namely, improved biomaterial coatings containing antimicrobial substances and modified implant surfaces with anti-adhesive properties56,57,58,59. Furthermore, the production of polysaccharide intercellular adhesin (PIA), whose synthesis is mediated by the intercellular adhesion (icaADBC) locus, is thought to play an important role during the accumulative phase of the formation of a staphylococcal biofilm, and because the ica locus was initially discovered in S. epidermidis, for a long time it was even considered to be a primary virulence factor with regard to S. epidermidis-related implant infections35,60. However, differences in the biofilm formation mechanisms of S. aureus and S. epidermidis have been recognized34, and whereas carriage of the ica locus is strongly related to the biofilm-forming ability in S. epidermidis strains60, the relationship between ica locus carriage and the biofilm-forming ability in S. aureus is ambiguous, even though this locus also resides in almost all S. aureus strains61. Moreover, icaADBC-independent biofilm mechanisms involving cell surface components have been described in S. aureus62 and a novel S. aureus biofilm phenotype mediated by the LPXTG-anchored FnBPs (where LPXTG is a specific recognition motif) has received increasing attention in recent researches, which indicate that the FnBP-promoted biofilm mechanism may be a pivotal determinant of virulence in implant infection36,63,64.

In this work, our experimental data demonstrated that Ag-incorporated titania coatings can effectively inhibit two types of biofilm formation by regulating the expression levels of related genes. For S. epidermidis biofilms, since the co-expression of icaA and icaD is essential for full PIA synthesis65,66 and the icaADBC operon is adversely regulated by the repressor encoded by an upstream gene icaR67,68, we examined icaA and icaR transcription levels as an index for the evaluation of biofilm formation. In our study, our real-time PCR results demonstrated that Ag-0.01 surfaces can downregulate the expression of icaA while upregulating the transcription level of icaR, and we could not detect the expression of icaA or icaR on the Ag-0.1 surfaces because of the low level of bacterial RNA present. For S. aureus biofilms, the fnbA and fnbB genes are required for FnBP-mediated biofilm development36; therefore, we assessed the expression levels of these genes. Our results showed that the Ag-0.01 samples significantly downregulated fnbA and fnbB expression. Therefore, we conclude that the inhibition of the transcription of biofilm- related genes gave rise to a reduction in PIA/FnBP production and thus decreased biofilm formation and enhanced the susceptibility of the sessile bacteria to the Ag.

By virtue of the simplicity and flexibility with which surface morphology and chemical composition can be adjusted, hydrothermal amelioration is regarded as a hopeful chemical processing method for endowing Ti-based biomaterials with increased functionality25. Moreover, the synergetic effect of the hierarchical surface construction of a titania micropore/nanoawl coating and the incorporation of the nutrient elements of calcium and phosphorus may offset the cytotoxicity of Ag through optimization of the material design and the Ag doping content. With regard to our novel bacteria-cell co-culture investigation, the obtained results demonstrate that once sufficient bacteria have invaded during the perioperative period, mammalian cells will not win the race for occupation of the implant surface without the action of antibacterial agents that can restrain biofilm formation, thus preventing implant infection. However, if the dose of antibacterial agents is too high, it may damage the cells themselves in addition to effectively killing bacteria. Our bacteria-fibroblast co-culture study demonstrated that our Ag-0.01 samples could help fibroblast cells to triumph over the two tested types of bacteria, striking a balance between anti-infective activity and cytocompatibility, which holds great promise for orthopaedic clinical applications.

Materials and Methods

Fabrication of specimens

Commercial pure Ti (Grade 1, purity>99.85 wt%) plates with dimensions of 10 × 10 × 1 mm3 and 20 × 20 × 1 mm3 were first ultrasonically cleaned, followed by PEO treatment to form a layer of titania coating on the Ti surface in an electrolyte containing calcium acetate monohydrate and glycerophosphate disodium salt pentahydrate. Subsequently, a hydrothermal treatment in silver acetate solution (0 g/L, 0.01 g/L or 0.1 g/L) was applied at 140 °C for 24 h in a Teflon-lined steel reaction vessel to deposit Ag nanoparticles. The PEO-derived titania coating was used as the control (designated as “TiO2”), and the hydrothermally treated samples described above were designated as “Ag-0”, “Ag-0.01”, and “Ag-0.1”, respectively.

Surface characterization of specimens

The surface morphology of the specimens was examined via field emission scanning electron microscopy (FESEM; S-4800, HITACHI, Japan). Their crystallinity was investigated using an X-ray diffractometer (XRD; D/Max, Rigaku, Tokyo, Japan) fitted with a Cu Kα (λ = 1.541 Å) source at 40 kV and 100 mA, in the range of 2θ = 10~90° at a step size of 0.02°. Phase identification was performed using the standard JCPDS database. In the X-ray diffraction measurements, the glancing angle of the incident beam against the sample surface was fixed at 1°. Raman spectra were recorded from 0 to 1000 cm−1 using a Raman microscope system (LabRAM, Horiba Jobin Yvon, France) with an Ar-ion laser at 20 mW (514.5 nm) for excitation. The surface chemical composition and chemical state of were analyzed by X-ray photoelectron spectroscopy (XPS; PHI 5802, Physical Electronics Inc, Eden Prairie, MN) with an Mg Kα (1253.6 eV) source, and TEM analysis was performed using a field emission transmission electron microscope (TEM; JEM-2100F, JEOL Ltd, Tokyo, Japan) with an accelerating voltage of 200 kV. Each sample for examination was scratched off from the surface of a specimen and dispersed in ethanol. A droplet of the resulting suspension was placed on a holey copper grid covered with a porous carbon film.

Ion release measurement

The TiO2, Ag-0, Ag-0.01 and Ag-0.1 samples were soaked in 10 ml of agar-free TSB medium and fresh water in 15 ml sterile microcentrifuge tubes, followed by successive incubation for 1, 4, 7 and 14 d at 37 °C. After each incubation period, the leachates were collected and the amounts of silver, calcium, phosphorus and titanium ions released were determined via inductively coupled plasma optical emission spectrometry (ICP-OES, Varian Liberty 150, US).

SBF test of apatite-forming ability

The TiO2, Ag-0, Ag-0.01 and Ag-0.1 samples were soaked in simulated body fluid (SBF) for 7 and 14 d to estimate their apatite-forming ability. The SBF was prepared by dissolving reagent-grade NaCl, NaHCO3, KCl, K2HPO4·3H2O, MgCl2·6H2O, CaCl2, and Na2SO4 in deionized water and was buffered to pH 7.4 with tris-hydroxymethyl-aminomethane (Tris) and HCl at 36.5 °C26. Two samples per group were soaked in a plastic vial containing 20 ml of SBF, and then placed in a biological thermostat at 36.5 °C under static conditions. At the end of the desired time, the samples were extracted from the SBF, gently washed with deionized water and allowed to dry naturally at room temperature.

In vitro cytotoxicity evaluation

Fibroblast-like cells (HT1080, Shanghai Institute of Biological Science, Chinese Academy of Sciences) were utilized to determine the cytocompatibility of the samples and the cytotoxicity was analysed using the Cell Counting Kit-8 (CCK-8, Beyotime Bio-Tech, China) assay. The cells were grown in Dulbecco’s modified Eagle medium (DMEM, Gibco, USA) supplemented with 10% foetal bovine serum (FBS, Gibco, USA) and were maintained in a moist environment at 37 °C with 5% CO2. Each sample was placed in one well of a 24-well plate and cells with a density of 3 × 104 cells/ml were seeded onto each sterile specimen. After 1 and 4 days of incubation, the culture medium was removed from the 24-well plate and each well was supplemented with 1 ml of fresh cell growth medium containing 100 μl of CCK-8 and placed in the incubator for 2 h. Finally, 100 μl of culture medium was transferred to a new 96-well plate, and the optical density was measured by a microplate reader (BIO-TEK, ELX 800) at 450 nm wavelength. All analyses were performed in triplicate.

Bacterial source and culture

S. epidermidis (RP62A) was purchased in freeze-dried form from the American Type Culture Collection (Rockefeller, MD), and methicillin-resistant S. aureus (USA 300) was kindly provided by Dr. Binh An Diep (Department of Medicine, University of California, San Francisco, USA). For our test, the two types of bacteria were grown in a trypticase soy broth (TSB; BD Biosciences, Franklin Lakes, NJ) medium at 37 °C overnight. Then, the concentration of the S. epidermidis suspension was adjusted to ~1 × 106 colony forming units (CFU)/ml based on the McFarland standard in TSB containing 1% (w/v) glucose (TSBG), and the concentration of the S. aureus suspension was also diluted to ~1 × 106 CFU/ml based on the McFarland standard in 1%TSBG supplemented with human plasma. Human plasma was obtained from healthy adult donors at Shanghai Jiao Tong University Affiliated Sixth People’s Hospital. Our study protocol was approved by the Shanghai Jiao Tong University Affiliated Sixth People’s Hospital Ethics Committee, and it complies with the moral principles of the Helsinki declaration of 2000. All donors signed a written informed consent form before entry into our study. Sterile specimens were placed in new 24-well plates, and 500 μl of bacterial suspension was added into each well containing a specimen. Afterwards, the samples were statically incubated overnight (for 18 hours) at 37 °C for a subsequent evaluation of antibacterial activity.

Quantitative and qualitative evaluation of antibacterial efficiency

At the end of our test, the amounts of viable planktonic bacteria present in original medium were examined through the SPM (spread plate method, namely, bacterial suspensions were serially diluted with fresh PBS, evenly spread on sheep blood agar (SBA) plates, and incubated overnight at 37 °C.)8. The number of CFU on each SBA plate was calculated using the protocol specified by the Chinese National Standard GB/T 4789.2, and typical experimental results were photographically recorded for qualitative evaluation of the planktonic bacteria. Then, the specimens were extracted from the medium using sterile forceps, and any non-adherent bacteria on the samples were gently rinsed away with fresh PBS. Moreover, each foil sample was placed in 1 ml of fresh PBS and subjected to ultrasonic vibration (150 W, B3500S-MT, Branson Ultrasonics Co., Shanghai, China) for 5 min to separate the attached bacteria, and then, after vortex mixing, we drew a sample of the final suspension to calculate the live bacteria using the SPM. Each experiment was repeated three times.

Qualitative evaluation of bacterial biofilms by SEM

The incubated samples were lightly washed twice with sterile PBS, fixed with 2.5% glutaraldehyde at 4 °C for 18 h, and sequentially dehydrated in the scalar ethanol series (50, 70, 80, 90,95 v/v%) once (for 15 min) and then in absolute ethanol twice (for 15 min each time). Then, the specimens were desiccated, sprayed with gold, and ultimately observed via scanning electron microscopy (SEM; JEOL JSM-6310LV, Japan).

Qualitative evaluation of bacterial biofilms by CLSM

The incubated samples were lightly washed twice with sterile PBS, placed in a new 24-well plate, stained with 1 ml of mixed dye (LIVE/DEAD BacLight bacteria viability kits, Invitrogen) for 20 min, gently rinsed once with sterile PBS and finally imaged via confocal laser scanning microscopy (CLSM; LSM 510 meta, Zeiss, Germany). Live bacteria with intact cytomembranes were stained green, whereas dead bacteria with damaged cell membranes were stained red.

qRT-PCR analysis of related gene transcription for two representative biofilms

The genes involved in the formation of the two types of biofilms were quantitatively tested via real-time polymerase chain reaction (PCR). We added 2 ml of bacterial suspension (106 CFU/ml) into each well containing a sample (2 cm square) in a 6-well plate and statically cultivated the plate at 37 °C overnight. S. epidermidis RP62A was selected for the icaA and icaR expression assays and MRSA USA300 was selected for the fnbA and fnbB expression assays. After the incubation period, the adhering bacteria were collected and pelleted via centrifugation at 10,000 g for 5 min and then resuspended in 1 ml of PBS with 100 mg/ml of lysostaphin (Sigma) and incubated for 10 min at 37 °C33. Total RNA extraction was performed using the RNeasy Mini Kit (Qiagen, Germany). Then, 1 μg of the total RNA was reverse transcribed to its complementary DNA (cDNA) using the PrimeScript RT reagent kit (Takara), and qRT-PCR analysis was performed on a Bio-Rad C1000 system using SYBR Premix Ex Taq II (Takara). Commercially synthesized primers related to the target genes were used, as presented in Table 2. The expression levels of icaA, icaR, fnbA and fnbB were assessed and normalized with respect to that of the internal standard gene 16S rRNA. The quantification of the expression of the target genes was grounded on a cycle threshold value for each sample that was computed by averaging three replicate measurements33,69.

Table 2: Primers used in the present study for real-time polymerase chain reaction.

In vitro co-culture experiments with bacteria and fibroblast cells

Based on previous research7,40, our in vitro co-culture study was performed by sequentially applying bacteria (RP62A/USA300) and fibroblast cells to the sample surfaces. First, 25 μl volumes of bacterial suspensions (105 CFU/ml) were applied to the specimens and incubated for 90 min at 37 °C. Second, fibroblasts in modified culture medium were distributed on the sample surfaces at a density of 105 cells/well in a 24-well plate and then incubated for 36 h in 5% CO2 at 37 °C. This modified medium contained cell growth medium and TSB. Ultimately, at the end of the experiment, the samples were fixed in 4% paraformaldehyde, stained with TRITC-phalloidin and DAPI, and imaged using a fluorescence microscope (Leica Microsystems LTD, Germany). The results were quantitatively evaluated based on the surface coverage of the foils by fibroblasts in the presence of contaminated bacteria, and the analysis was performed as described in previous reports.

Statistical analysis

All studies were implemented in triplicate. All data are expressed as the mean ± standard deviation (SD). Under the assumption of normal distributions and equal variances, one-way ANOVA and SNK post-hoc analyses were applied to perform statistical comparisons between groups, and P values of less than 0.05 were considered statistically significant.


In summary, TiO2 coating with a hierarchical hybrid micro/nanostructure of incorporated Ag-nanoparticles were first prepared on Ti surfaces to develop a delivery platform that could provide the sustained release of silver ions. Then, it was demonstrated that these modified surfaces exhibit good antimicrobial properties against both adherent bacteria and planktonic bacteria for two representative strains of epidemic Staphylococcus (S. epidermidis, RP62A; MRSA, USA 300). The modified surfaces can regulate the expression levels of biofilm-related genes (icaA and icaR for S. epidermidis; fnbA and fnbB for MRSA) to inhibit bacterial adhesion and biofilm formation. In addition, a bacteria-cell co-culture investigation revealed that the incorporation of Ag nanoparticles on a Ti surface can help mammalian cells to survive, adhere and spread more successfully than Staphylococcus, resulting in a mammalian cell-assisting antibacterial functionality. Besides, the modified surfaces also showed good bioactivity. This study represents a meaningful attempt to provide new insight into the antibacterial behavior and mechanisms of Ag-nanoparticle-functionalized Ti implant surfaces with bacteria-killing and cell-assisting functionalities, thereby paving the way towards better satisfying clinical needs in orthopedic applications.

Additional Information

How to cite this article: Wang, J. X. et al. Silver-nanoparticles-modified biomaterial surface resistant to staphylococcus: new insight into the antimicrobial action of silver. Sci. Rep. 6, 32699; doi: 10.1038/srep32699 (2016).


  1. 1.

    , & Surface modification of titanium, titanium alloys, and related materials for biomedical applications. Mater. Sci. Eng. R. 47, 49–121 (2004).

  2. 2.

    , & The significance of infection related to orthopedic devices and issues of antibiotic resistance. Biomaterial 27, 2331–2339 (2006).

  3. 3.

    , & A review of the clinical implications of anti-infective biomaterials and infection-resistant surfaces. Biomaterials 34, 8018–8029 (2013).

  4. 4.

    , & A review of the biomaterials technologies for infection-resistant surfaces. Biomaterials 34, 8533–8554 (2013).

  5. 5.

    Treatment of infections associated with surgical implants. N Engl J Med. 350, 1422–1429 (2004).

  6. 6.

    , & Enhanced osteoblast functions and bactericidal effect of Ca and Ag dual-ion implanted surface layers on nanograined titanium alloys. J. Mater. Chem. B. 2, 4531–4543 (2014).

  7. 7.

    , , , & Simultaneous interaction of bacteria and tissue cells with photocatalytically activated, anodized titanium surfaces. Biomaterials 35, 2580–2587 (2014).

  8. 8.

    et al. In vitro and in vivo anti-biofilm effects of silver nanoparticles immobilized on titanium. Biomaterials 35, 9114–9125 (2014).

  9. 9.

    et al. Nano-thick calcium oxide armed titanium: boosts bone cells against methicillin-resistant Staphylococcus aureus. Sci.Rep. 6, 21761 (2016).

  10. 10.

    et al. The construction of hierarchical structure on Ti substrate with superior osteogenic activity and intrinsic antibacterial capability. Sci. Rep. 4, 6172 (2014).

  11. 11.

    et al. Effect of UV-photofunctionalization on oral bacterial attachment and biofilm formation to titanium implant material. Biomaterials 67, 84–92 (2015).

  12. 12.

    et al. The inhibition of Staphylococcus epidermidis biofilm formation by vancomycin-modified titanium alloy and implications for the treatment of periprosthetic infection. Biomaterials 29, 4684–4690 (2008).

  13. 13.

    et al. Antimicrobial efficacy of combined clarithromycin plus daptomycin against biofilms-formed methicillin-resistant Staphylococcus aureus on titanium medical devices. J Infect Chemother. 21, 756–759 (2015).

  14. 14.

    & “Nanoantibiotics”: A new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era. J Control Release 156, 128–145 (2011).

  15. 15.

    et al. Emerging rules for effective antimicrobial coatings. Trends Biotechnol. 32, 82–90 (2014).

  16. 16.

    et al. Antimicrobial effects of silver nanoparticles. Nanomedicine 3, 95–101 (2007).

  17. 17.

    et al. The progress of silver nanoparticles in the antibacterial mechanism, clinical application and cytotoxicity. Mol Biol Rep. 39, 9193–9201 (2012).

  18. 18.

    , & Nanosilver as a new generation of nanoproduct in biomedical applications. Trends Biotechnol. 28, 580–588 (2010).

  19. 19.

    et al. Antimicrobial silver: An unprecedented anion effect. Sci. Rep. 4, 7161 (2014).

  20. 20.

    , & Silver nanoparticles: a brief review of cytotoxicity and genotoxicity of chemically and biogenically synthesized nanoparticles. J Appl Toxicol. 32, 867–879 (2012).

  21. 21.

    , , , & In vitro cytotoxicity of silver nanoparticles on osteoblasts and osteoclasts at antibacterial concentrations. Nanotoxicology 7, 30–36 (2013).

  22. 22.

    , , , & Existence, release, and antibacterial actions of silver nanoparticles on Ag-PIII TiO2 films with different nanotopographies. Int J Nanomedicine 9, 3389–3402 (2014).

  23. 23.

    & Silver as antibacterial agent: ion, nanoparticle, and metal. Angew Chem Int Ed Engl. 52, 1636–1653 (2013).

  24. 24.

    et al. Titanium nanostructures for biomedical applications. Nanotechnology 26, 062002 (2015).

  25. 25.

    et al. Chemically regulated bioactive ion delivery platform on a titanium surface for sustained controlled release. J. Mater. Chem. B. 2, 283–294 (2014).

  26. 26.

    et al. Enhanced bioactivity and bacteriostasis effect of TiO2 nanofilms with favorable biomimetic architectures on titanium surface. RSC Advances 3, 11214–11225 (2013).

  27. 27.

    , & Application of plasma electrolytic oxidation to bioactive surface formation on titanium and its alloys. RSC Advances 3, 19725–19743 (2013).

  28. 28.

    , , & Enhanced osteoblast functions of narrow interligand spaced Sr-HA nano-fibers/rods grown on microporous titania coatings. RSC Advances 3, 11169–11184 (2013).

  29. 29.

    , & Direct role of interrod spacing in mediating cell adhesion on Sr-HA nanorod-patterned coatings. Int J Nanomedicine 9, 1243–1260 (2014).

  30. 30.

    & Effect of hydrothermal treatment model on the formation of Sr-HA nanorod arrays on microarc oxidized titania coatings. Appl. Surf. Sci. 286, 384–390 (2013).

  31. 31.

    , , , & Evaluation of magnesium ions release, biocorrosion, and hemocompatibility of MAO/PLLA-modified magnesium alloy WE42. J Biomed Mater Res B Appl Biomater 96, 101–109 (2011).

  32. 32.

    , , , & Enhancing biocompatibility and corrosion resistance of Mg implants via surface treatments. J Biomater Appl. 27, 469–476 (2012).

  33. 33.

    et al. The use of quaternised chitosan-loaded PMMA to inhibit biofilm formation and downregulate the virulence-associated gene expression of antibiotic-resistant staphylococcus. Biomaterials 33, 365–377 (2012).

  34. 34.

    ica and beyond: biofilm mechanisms and regulation in Staphylococcus epidermidis and Staphylococcus aureus. FEMS Microbiol Lett. 270, 179–188 (2007).

  35. 35.

    , , , & Biofilm formation in Staphylococcus implant infections. A review of molecular mechanisms and implications for biofilm-resistant materials. Biomaterials 33, 5967–5982 (2012).

  36. 36.

    et al. A novel Staphylococcus aureus biofilm phenotype mediated by the fibronectin-binding proteins, FnBPA and FnBPB. J Bacteriol. 190, 3835–3850 (2008).

  37. 37.

    Biomaterial-centered infection: microbial adhesion versus tissue integration. Science 237, 1588–1595 (1987).

  38. 38.

    , & Bacterial biofilms: from the natural environment to infectious diseases. Nat Rev Microbiol. 2, 95–108 (2004).

  39. 39.

    , , , & Microbial biofilm growth vs. tissue integration: “the race for the surface” experimentally studied. Acta Biomater 5, 1399–1404 (2009).

  40. 40.

    et al. Soft tissue integration versus early biofilm formation on different dental implant materials. Dent mater 30, 716–727 (2014).

  41. 41.

    & Perioperative infection control: an update for patient safety in orthopedic surgery. Orthopedics 29, 329–339; quiz 340-321 (2006).

  42. 42.

    , , & Raman scattering characterization of gel-derived titania glass. J Mater Sci. 28, 177–183 (1993).

  43. 43.

    , & Electronic structures of ordered Ag-Mg alloys. Phys Rev B. 49, 4478–4484 (1994).

  44. 44.

    , & Bond ionicity and structural stability of some average-valence-five materials studied by x-ray photoemission. Phys Rev B. 15, 1680–1697 (1977).

  45. 45.

    et al. Antibacterial activity and increased bone marrow stem cell functions of Zn-incorporated TiO2 coatings on titanium. Acta Biomater 8, 904–915 (2012).

  46. 46.

    , , & CuO/Cu(OH)2 hierarchical nanostructures as bactericidal photocatalysts. J. Mater. Chem. 21, 9634–9640 (2011).

  47. 47.

    et al. Pathogenic analysis in different types of orthopedic implant infections. Chin Med J (Engl). 127, 2748–2752 (2014).

  48. 48.

    , , , & Effect of biofilms on recalcitrance of staphylococcal joint infection to antibiotic treatment. J Infect Dis. 211, 641–650 (2015).

  49. 49.

    et al. Plasma-treated nanostructured TiO2 surface supporting biomimetic growth of apatite. Biomaterials 26, 6143–6150 (2005).

  50. 50.

    et al. A mechanistic study of the antibacterial effect of silver ions on Escherichia coli and Staphylococcus aureus. J Biomed Mater Res. 52, 662–668 (2000).

  51. 51.

    et al. The inhibitory effects of silver nanoparticles, silver ions, and silver chloride colloids on microbial growth. Water Res. 42, 3066–3074 (2008).

  52. 52.

    & Nitrification inhibition by silver nanoparticles. Water Sci Technol. 59, 1699–1702 (2009).

  53. 53.

    & Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for Gram-negative bacteria. J Colloid Interface Sci. 275, 177–182 (2004).

  54. 54.

    , & The biological effects and possible modes of action of nanosilver. Rev Environ Contam Toxicol. 223, 81–106 (2013).

  55. 55.

    , & Biofilm in implant infections: its production and regulation. Int J Artif Organs 28, 1062–1068 (2005).

  56. 56.

    , , , & Furanones, potential agents for preventing Staphylococcus epidermidis biofilm infections? J Antimicrob Chemother . 63, 309–316 (2009).

  57. 57.

    , , , & Bioactive titanium implant surfaces with bacterial inhibition and osteoblast function enhancement properties. Int J Artif Organs 31, 777–785 (2008).

  58. 58.

    et al. Antimicrobial peptides on calcium phosphate-coated titanium for the prevention of implant-associated infections. Biomaterials 31, 9519–9526 (2010).

  59. 59.

    , , , & Silk-functionalized titanium surfaces for enhancing osteoblast functions and reducing bacterial adhesion. Biomaterials 29, 4751–4759 (2008).

  60. 60.

    et al. Detection of the intercellular adhesion gene cluster (ica) and phase variation in Staphylococcus epidermidis blood culture strains and mucosal isolates. Infect Immun. 65, 890–896 (1997).

  61. 61.

    et al. Association between methicillin susceptibility and biofilm regulation in Staphylococcus aureus isolates from device-related infections. J Clin Microbiol. 45, 1379–1388 (2007).

  62. 62.

    , , , & Essential role for the major autolysin in the fibronectin-binding protein-mediated Staphylococcus aureus biofilm phenotype. Infect Immun. 79, 1153–1165 (2011).

  63. 63.

    , & Carriage of both the fnbA and fnbB genes and growth at 37 degrees C promote FnBP-mediated biofilm development in meticillin-resistant Staphylococcus aureus clinical isolates. J Med Microbiol. 58, 399–402 (2009).

  64. 64.

    et al. Relevant role of fibronectin-binding proteins in Staphylococcus aureus biofilm-associated foreign-body infections. Infect Immun. 77, 3978–3991 (2009).

  65. 65.

    et al. Detection of biofilm formation in Staphylococcus epidermidis from implant infections. Comparison of a PCR-method that recognizes the presence of ica genes with two classic phenotypic methods. J Biomed Mater Res A. 76, 425–430 (2006).

  66. 66.

    , & Presence of icaA and icaD genes and slime production in a collection of staphylococcal strains from catheter-associated infections. J Clin Microbiol. 39, 2151–2156 (2001).

  67. 67.

    , & icaR encodes a transcriptional repressor involved in environmental regulation of ica operon expression and biofilm formation in Staphylococcus epidermidis. J Bacteriol. 184, 4400–4408 (2002).

  68. 68.

    et al. Crystal structure of IcaR, a repressor of the TetR family implicated in biofilm formation in Staphylococcus epidermidis. Nucleic Acids Res. 36, 1567–1577 (2008).

  69. 69.

    et al. Human beta-defensin 3 inhibits antibiotic-resistant Staphylococcus biofilm formation. J Surg Res. 183, 204–213 (2013).

Download references


The authors gratefully acknowledge the support from the National Basic Research Program of China (973 Program, 2012CB933600), the National Natural Science Foundation of China (Grant No. 81271962, 81472109, 81472108), the National Science Fund for Distinguished Young Scholars (51525207), the Shanghai Committee of Science and Technology, China (15441904900, 14XD1403900), and the Special Research Project of Health Care Industry (No. 201302007) supported by the Ministry of Public Health of China.

Author information

Author notes

    • Jiaxing Wang
    • , Jinhua Li
    •  & Geyong Guo

    These authors contributed equally to this work.


  1. Department of Orthopaedics, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai Jiao Tong University, Shanghai 200233, China

    • Jiaxing Wang
    • , Geyong Guo
    • , Qiaojie Wang
    • , Yaochao Zhao
    • , Hui Qin
    • , Tuerhongjiang Wahafu
    • , Hao Shen
    •  & Xianlong Zhang
  2. State Key Laboratory of High Performance Ceramics and Superfine Microstructure, Shanghai Institute of Ceramics, Chinese Academy of Sciences, Shanghai 200050, China

    • Jinhua Li
    •  & Xuanyong Liu
  3. University of Chinese Academy of Sciences, Beijing 100049, China

    • Jinhua Li
  4. Department of Clinical Laboratory, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai Jiao Tong University, Shanghai 200233, China

    • Jin Tang


  1. Search for Jiaxing Wang in:

  2. Search for Jinhua Li in:

  3. Search for Geyong Guo in:

  4. Search for Qiaojie Wang in:

  5. Search for Jin Tang in:

  6. Search for Yaochao Zhao in:

  7. Search for Hui Qin in:

  8. Search for Tuerhongjiang Wahafu in:

  9. Search for Hao Shen in:

  10. Search for Xuanyong Liu in:

  11. Search for Xianlong Zhang in:


All authors contributed to the manuscript. X.Z., X.L. and H.S. conceived and designed the experiments. J.L. fabricated and characterized the materials. J.W., J.L., G.G., Q.W., J.T., Y.Z., H.Q. and T.W. performed the experiments and analyzed the data. J.W., J.L. and G.G. interpreted the data and wrote the manuscript. X.Z., X.L. and H.S. supervised and co-wrote the manuscript. All of the authors reviewed the manuscript.

Competing interests

The authors declare no competing financial interests.

Corresponding authors

Correspondence to Hao Shen or Xuanyong Liu or Xianlong Zhang.


By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Creative Commons BYThis work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit